CGLDIL
Diluent C for General Membrane Labeling
Distributed for Phanos Technologies
Synonym(s):
PKH diluent
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.32
UNSPSC Code:
12352207
Quality Level
form
liquid
storage condition
dry at room temperature
technique(s)
flow cytometry: suitable
application(s)
cell analysis
detection
detection method
fluorometric
shipped in
ambient
storage temp.
room temp
Application
Diluent C for general membrane labeling has been used for the complete dispersion of mesenchymal stem cells (MSCs) pellets. It may also be used as a general membrane labeling diluent with PKH26, PKH67 and CellVue® Claret fluorescent cell linker dyes.
Other Notes
For additional technical details on PKH and CellVue® Fluorescent Cell Linker Dyes including an extensive bibliography, please visit here.
Legal Information
Distributed for Phanos Technologies, Inc.
CellVue is a registered trademark of Phanos Technologies
Kit Components Only
Product No.
Description
- Diluent C 6 vial(s)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
PKH和CellVue® 荧光细胞连接子试剂盒可提供长时间的活细胞荧光标记，且无明显毒性作用。
PKH and CellVue® Fluorescent Cell Linker Kits provide fluorescent labeling of live cells over an extended period of time, with no apparent toxic effects.
Related Content
Phenotypic plasticity of mesenchymal stem cells is crucial for mesangial repair in a model of immunoglobulin light chain-associated mesangial damage
Herrera GA, et al.
Ultrastructural Pathology, 42(3), 262-288 (2018)
Lei Wu et al.
Frontiers in immunology, 11, 1934-1934 (2020-10-06)
Long non-coding RNA (lncRNA) is pivotal for multiple sclerosis (MS), but the potential mechanism of lncRNA PVT1 in MS animal model, experimental autoimmune encephalomyelitis (EAE) still remains unclear. In this study, macrophages were firstly isolated and induced to polarize into
Guillermo A Herrera et al.
Ultrastructural pathology, 42(3), 262-288 (2018-04-19)
Mesangiopathies produced by glomerulopathic monoclonal immunoglobulin light chains (GLCs) acting on the glomerular mesangium produce two characteristic lesions: AL-amyloidosis (AL-Am) and light chain deposition disease (LCDD). In both cases, the pathology is centered in the mesangium, where initial and progressive
Global Trade Item Number
| SKU | GTIN |
|---|---|
| CGLDIL-6X10ML | 04061833531754 |